Biochemical pharmacologyMetabolic ReprogrammingHumansArthritisRheumatoidOsteoarthritis
The role of metabolic reprogramming in inflammatory bone diseases.
Yu-Han Wang, Lu Zhou, Lu Zhang
Published: 202610.1016/j.bcp.2025.117541
Abstract
Inflammatory bone diseases are characterized by bone destruction, resulting from an imbalance between bone resorption and formation due to chronic inflammation. The dynamic equilibrium among osteoblasts, osteoclasts, and various immune cells is cruci…
Preview only. Read the full abstract at the source